We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$2.11B
AUM Growth
+$194M
Cap. Flow
+$818M
Cap. Flow %
38.75%
Top 10 Hldgs %
58.11%
Holding
879
New
298
Increased
119
Reduced
90
Closed
306

Sector Composition

Rank Sector Weight
1 Healthcare 15.03%
2 Consumer Discretionary 11.05%
3 Financials 5.53%
4 Technology 3.61%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGS.WS
251
DELISTED
Simon Property Group Acquisition Holdings, Inc. Warrants, each exercisable for one Class A common stock at an exercise price of $11.50 per share
SPGS.WS
$216K 0.01%
+218,321
New +$287K
XLRN
252
PUT
DELISTED
Acceleron Pharma
XLRN
$216K 0.01%
+50,400
New +$6.59M
SCPL
253
CALL
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$214K 0.01%
+69,500
New +$1.23M
GNACW
254
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$211K 0.01%
300,846
+140,422
+88% +$126K
TRIP icon
255
CALL
TripAdvisor
TRIP
$1.26B
$207K 0.01%
58,500
+18,500
+46% +$663K
COOK icon
256
Traeger
COOK
$172M
$206K 0.01%
+196
New +$245K
NXU.WS
257
DELISTED
Novus Capital Corporation II Redeemable warrants, each whole warrant exercisable for shares of Class
NXU.WS
$206K 0.01%
188,820
+115,594
+158% +$129K
WFC icon
258
Wells Fargo
WFC
$265B
$205K 0.01%
4,422
-18,444
-81% -$854K
FLNA
259
CALL
Filana Therapeutics
FLNA
$48.2M
$204K 0.01%
+12,500
New +$1.04M
CCXI
260
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$204K 0.01%
23,200
+1,200
+5% +$18.7K
TLIS
261
CALL
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$199K 0.01%
+9,833
New +$1.31M
GRNAW
262
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$199K 0.01%
+197,508
New +$207K
LDHAU
263
DELISTED
LDH Growth Corp I Units
LDHAU
$197K 0.01%
+20,000
New +$198K
CORT icon
264
Corcept Therapeutics
CORT
$12.3B
$196K 0.01%
9,935
-28,899
-74% -$605K
PIII icon
265
P3 Health Partners
PIII
$42.7M
$193K 0.01%
392
-9,608
-96% -$4.73M
IIAC
266
DELISTED
Investindustrial Acquisition Corp.
IIAC
$192K 0.01%
+19,292
New +$191K
AGGRW
267
DELISTED
Agile Growth Corp Warrant
AGGRW
$188K 0.01%
+296,138
New +$236K
BKSY icon
268
BlackSky Technology
BKSY
$1.17B
$186K 0.01%
+2,250
New +$185K
CLVS
269
DELISTED
Clovis Oncology, Inc.
CLVS
$185K 0.01%
+41,492
New +$200K
ARBGW
270
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$184K 0.01%
307,833
+139,325
+83% +$109K
SLVRU
271
DELISTED
SilverSPAC Inc. Unit
SLVRU
$180K 0.01%
+18,098
New +$179K
AAC.WS
272
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$179K 0.01%
+210,018
New +$227K
WKHS icon
273
PUT
Workhorse Group
WKHS
$34.5M
$178K 0.01%
71
-31
-30% -$938K
RKLB icon
274
Rocket Lab Corp
RKLB
$50B
$173K 0.01%
+10,700
New +$129K
KLAQW
275
DELISTED
KL Acquisition Corp Warrant
KLAQW
$173K 0.01%
240,327
+150,803
+168% +$119K

Similar funds

Cowen and Company's Q3 2021 Portfolio in Review

As of Q3 2021, Cowen and Company held 879 positions worth $2.11B, up 10% from $1.92B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Cowen and Company deployed $818M of net new capital in Q3 2021, opening 298 new positions and adding to 119 existing holdings. Its largest new stake was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Nice, an estimated $7.38M trimmed.

  • Cowen and Company's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 1,190,000 shares worth $48.3M.
  • Cowen and Company added most to FTAI Aviation in Q3 2021, an estimated $42.9M increase.
  • Cowen and Company's biggest Q3 2021 reduction was Nice, cutting an estimated $7.38M.
  • Cowen and Company fully exited Foley Trasimene Acquisition Corp. in Q3 2021, selling an estimated $15.1M.
  • Cowen and Company's ten largest holdings make up 58% of its $2.11B portfolio in Q3 2021.
  • Cowen and Company opened 298 new positions and closed 306 in Q3 2021.
  • Cowen and Company's portfolio value rose 10% quarter-over-quarter to $2.11B.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.